Sitagliptin showed greater glycemic efficacy over dapagliflozin when added onto existing therapy.

The SUSTAIN trials showed significant reductions in weight, but the true reason for the weight loss still unknown.

Recent studies show one-quarter of the population over the age of 75 who have type 2 diabetes are tightly managed with medications and are high risk for hypoglycemia.

SGLT shown as useful adjunctive agent when insulin monotherapy fails, but decrease in insulin use may prove harmful.

Scientists find dramatic weight loss may reverse type 2 diabetes in some patients.

Do you have a program in place to improve medication compliance? Follow the link to see how you and your colleagues compare.

What proportion of Americans age 45 years and older have self-reported memory problems -- is it 1 in 30, 1 in 16, 1 in 9, or 1 in 4? Follow the link for the answer.

Prevalence of frailty 18 percent in middle-aged, older participants with four or more long-term conditions

Prevalences of diabetes and prediabetes higher among racial/ethnic minorities with mental illness

Large majority of surgical residents surveyed had a moderate- or high-risk debt-to-asset ratio